APOVAX, INC.

Basic Information

1044 E CHESTNUT ST
LOUISVILLE, KY, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 140646345
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates

    Amount: $803,836.00

    DESCRIPTION (provided by applicant): Pancreatic islet transplantation is a viable approach for the treatment of type 1 diabetes (T1D). However, this therapeutic approach suffers from graft rejection. ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government